Abstract
Introduction
inflammation diminishes. However, under persistent injury and inflammation, type 115 2 EMT can continue to generate myofibroblasts that accumulate and cause 116 progressive fibrosis, which may lead to organ destruction. In recent years, the 117 occurrence of type 2 EMT in vivo has been seriously challenged (33, 38, 60) .
118
Type 3 EMT occurs in cancer epithelial cells which undergo genetic and 119 epigenetic changes, and thus are able to invade and metastasize via the 120 circulation, thereby generating distant metastatic tumor. Type 3 EMT resembles 121 type 1 EMT in that generation of epithelia, rather than fibrosis, is typically the 122 ultimate outcome (15).
124
The focus of this review paper will be type 2 EMT in the context of liver disease, 125 especially liver fibrosis. We will summarize major evidence for/against the Hh signaling is a key morphogenic pathway that controls fetal liver development 160 and also plays an essential role in many types of adult liver injury. (16, 54) liver myofibroblasts) (56); and some mesenchymal markers lack specificity (e.g.,
250
Vimentin) (24). Moreover, it is difficult to determine co-localization of two markers 251 by immunohistochemistry. All these factors confound our efforts to identify a cell 252 as being (or not being) in the midst of an EMT, especially in whole tissues. An 253 additional challenge that we need to overcome is the fact that EMT and MET are 254 reversible processes. Hence, it is possible for a mesenchymal-type cell that was 255 derived from an epithelial cell to regain its epithelial traits (1, 15). 
EMT as SNAI1 and E-Cadherin were not involved (47). Hence, in hepatocytes,

285
EMT mechanisms appear to depend on the specific trigger (cytokines, 286 environment etc.), and this will also determine the markers that can be used to 287 characterize the particular EMT program. previous studies which claimed to refute the existence of EMT during liver injury.
511
Evidence for EMT/MET has also been observed recently by the same group 512 using a partial hepatectomy (PH) model (Swiderska-Syn et al., accepted by Gut).
513
This study found that in tamoxifen-treated αSMA-YFP mice, many progenitors, 514 cholangiocytes, and up to 25% of hepatocytes were YFP+ by 48-72 hours after 515 PH, indicating that liver epithelial cells were derived from αSMA-YFP+ cells.
516
What is particularly intriguing about these last two studies is that they identify 
